Lisa brings over 20 years of experience in CMC process development to Just – Evotec, working on a broad range of large molecule biotherapeutics at early and late stages of development. She currently leads the Process and Product Design group at the Seattle site, an innovative group of scientists and engineers that design cell lines, media, bioreactor and purification processes, analytics, drug product and automation for integrated, continuous manufacturing operations.
Prior to Just, Lisa spent 12 years at Amgen as a downstream group leader, with expertise in downstream process development and scale-up, batch and multi-column chromatography, high throughput resin screening, and viral clearance strategies. Additionally, she has been a CMC process team leader for several early and late stage monoclonal antibody, Fc fusion and biosimilar products. She has authored multiple regulatory filings for different jurisdictions and participated in face-to-face interactions with the FDA. Lisa received her Ph.D. in Biochemistry from Baylor College of Medicine in Houston TX, with a focus on the activity and regulation of cyclin-dependent kinases. She also completed a post-doc at Fred Hutchinson Cancer Research Center in Seattle, WA researching the role of cyclin dependent kinases in fruit fly nervous system development.